Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Walop

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|December 28, 2002
Influenza vaccine-associated adverse events: results of passive surveillance, Canada 2001-2002Y Choudhri, W Walop
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|February 19, 2002
Review of adverse events reported following use of yellow fever vaccine--Canada, 1987-2000Y Choudri, W Walop
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|August 13, 2002
Coding of drugs used by respondents of the Canadian Study of Health and AgingW Walop, M Semenchuk
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 15, 1987
Questionnaire development: 1. FormulationL Del Greco, W Walop
Chronic Diseases in Canada|February 15, 2001
Comparing two different approaches to measuring drug use within the same surveyC I Neutel, W Walop
Pharmacoepidemiology and Drug Safety|November 26, 2008
Where is the epidemiology in pharmacovigilance?C Ineke Neutel, W Walop
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 15, 1987
Questionnaire development: 5. The pretestL Del Greco, W Walop
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 15, 1987
Questionnaire development: 3. TranslationL Del Greco, W Walop, L Eastridge
L'Union Medicale Du Canada|May 1, 1980
[Epidemiology of breast feeding among mothers in a region of Montreal]M D Beaulieu, W Walop, C Wolfson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 1, 1987
Questionnaire development: 2. Validity and reliabilityL Del Greco, W Walop, R H McCarthy
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|December 28, 2002
Influenza vaccine-associated adverse events: results of passive surveillance, Canada 2001-2002Y Choudhri, W Walop
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|February 19, 2002
Review of adverse events reported following use of yellow fever vaccine--Canada, 1987-2000Y Choudri, W Walop
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|August 13, 2002
Coding of drugs used by respondents of the Canadian Study of Health and AgingW Walop, M Semenchuk
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 15, 1987
Questionnaire development: 1. FormulationL Del Greco, W Walop
Chronic Diseases in Canada|February 15, 2001
Comparing two different approaches to measuring drug use within the same surveyC I Neutel, W Walop
Pharmacoepidemiology and Drug Safety|November 26, 2008
Where is the epidemiology in pharmacovigilance?C Ineke Neutel, W Walop
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 15, 1987
Questionnaire development: 5. The pretestL Del Greco, W Walop
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 15, 1987
Questionnaire development: 3. TranslationL Del Greco, W Walop, L Eastridge
L'Union Medicale Du Canada|May 1, 1980
[Epidemiology of breast feeding among mothers in a region of Montreal]M D Beaulieu, W Walop, C Wolfson
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 1, 1987
Questionnaire development: 2. Validity and reliabilityL Del Greco, W Walop, R H McCarthy
Pageof 3